Friday, November 17, 2017 9:17:52 AM
Alternative Names: MCT 275
Latest Information Update: 04 Nov 2017
At a glance
Originator MultiCell Technologies Inc
Class
Mechanism of Action Immunosuppressants
Orphan Drug Status No
Highest Development Phases
No development reported Type 1 diabetes mellitus
Most Recent Events
04 Nov 2017 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in USA (Parenteral, Injection)
24 May 2006 Preclinical trials in Type-1-diabetes-mellitus in USA (unspecified route)
http://adisinsight.springer.com/drugs/800024474?query=all%3A%28%22multicell+technologies%22%29
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM